Reinhard Ruckser

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study.

QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study.

Journal: EJHaem

Published: February 12, 2024

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.

Journal: American journal of hematology

Published: August 25, 2023

Colorectal cancer

Colorectal cancer

Journal: Wiener medizinische Wochenschrift (1946)

Published: February 11, 2022

Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond.

Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond.

Journal: Cancers

Published: August 19, 2021

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Journal: Cancer discovery

Published: April 26, 2021

Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia.

Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia.

Journal: European journal of haematology

Published: July 08, 2020

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Journal: Cancers

Published: August 24, 2018

Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia.

Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia.

Journal: European journal of haematology

Published: March 20, 2018

Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure.

Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure.

Journal: Journal of clinical apheresis

Published: May 12, 2016

Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.

Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.

Journal: European journal of haematology

Published: March 31, 2016

Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.

Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.

Journal: International journal of clinical pharmacology and therapeutics

Published: December 11, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026